A look at Gerovital--the "youth" drug.
作者信息
Kent S
出版信息
Geriatrics. 1976 Dec;31(12):95-6, 101-2.
PMID:1001903
Abstract
The FDA is permitting controlled studies of the drug's possible antidepressant effects--but hasn't approved its use to "reverse" aging.
摘要
相似文献
1
A look at Gerovital--the "youth" drug.
Geriatrics. 1976 Dec;31(12):95-6, 101-2.
2
Gerovital-H3--a review of the literature.
Psychopharmacol Bull. 1975 Oct;11(4):51-3.
3
Possible rationale for procaine (Gerovital H3) therapy in geriatrics: inhibition of monoamine oxidase.
J Am Geriatr Soc. 1973 Sep;21(9):414-8. doi: 10.1111/j.1532-5415.1973.tb01701.x.
4
Gerovital H3 in the treatment of the depressed aging patient.
Psychosomatics. 1974;15(1):15-9. doi: 10.1016/S0033-3182(74)71288-9.
5
Procaine (Gerovital H3) therapy: mechanism of inhibition of monoamine oxidase.普鲁卡因（杰罗维它H3）疗法：单胺氧化酶抑制机制
J Am Geriatr Soc. 1974 Aug;22(8):365-71. doi: 10.1111/j.1532-5415.1974.tb04843.x.
6
7
Murine regional brain monoamine oxidase activity: time- and age-dependent response to inhibitors.小鼠脑区单胺氧化酶活性：对抑制剂的时间和年龄依赖性反应。
Gerontology. 1984;30(2):87-93. doi: 10.1159/000212613.
8
The systemic use of procaine in the treatment of the elderly: a review.
J Am Geriatr Soc. 1977 Jan;25(1):1-19. doi: 10.1111/j.1532-5415.1977.tb00917.x.
9
[Relation between glucose tolerance and depression and its therapy using monoamine oxidase inhibitors and lithium salts].
Nervenarzt. 1972 Jul;43(7):379-82.
10
Letter: Effect of procaine on ageing.信件：普鲁卡因对衰老的影响。
Lancet. 1973 Nov 10;2(7837):1087. doi: 10.1016/s0140-6736(73)92693-7.
Zotero 插件